Armando is not an actor but was compensated by Viiv Healthcare for his role in the advertisement. Alphonso Mills (attractive black gay man with dreadlocks) was the actor in the previous Dovato commercial “More to me; Alphonso" which was released on January 26, 2020.

How does Dovato work? The two active substances in Dovato, dolutegravir and lamivudine, block the activity of enzymes that the virus uses to make new copies of itself in the body.

Alphonso is a Black Gender Nonconforming person who grew up in a military family, obtained a Bachelor's Degree in Psychology from Morehouse College, and has worked with many HIV organizations in Atlanta and across the nation to raise awareness about living life to the fullest after being diagnosed with HIV.

Dovato can cause serious, life-threatening side effects. These include severe skin rash and allergic reactions, liver problems, a buildup of lactic acid in the blood (lactic acidosis), and drug interactions. Contact your health care provider right away if you develop a rash while taking Dovato.

In the US, the Food and Drug Administration (FDA) authorised Dovato, a complete, once-daily, single-tablet regimen of dolutegravir 50 mg and lamivudine 300 mg for the treatment of HIV-1 infection in adults with no antiretroviral (ARV) treatment history and with no known resistance to either dolutegravir or lamivudine.

Dovato has an average rating of 6.1 out of 10 from a total of 40 reviews on Drugs.com. 49% of reviewers reported a positive experience, while 38% reported a negative experience.

This product contains 2 drugs: dolutegravir and lamivudine. It is used to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life.

DOVATO is a fixed-dose combination product containing 50 mg of dolutegravir and 300 mg of lamivudine. The recommended dosage regimen of DOVATO in adults is one tablet taken orally once daily with or without food [see Clinical Pharmacology (12.3)].

Dovato has an average rating of 6.1 out of 10 from a total of 37 reviews for the treatment of HIV Infection.

Dolutegravir is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life.

DOVATO is a one-pill, once-a-day complete treatment for adults who are new to HIV-1 treatment or are replacing their current HIV-1 medicines. Take DOVATO exactly as your healthcare provider tells you.

In the US, the Food and Drug Administration (FDA) authorised Dovato, a complete, once-daily, single-tablet regimen of dolutegravir 50 mg and lamivudine 300 mg for the treatment of HIV-1 infection in adults with no antiretroviral (ARV) treatment history and with no known resistance to either dolutegravir or lamivudine.